AbbVie (NYSE: ABBV), announced today the availability of Refresh Advanced OMEGA-3 Lubricant Eye Drops in Canada. The new, ...

The stock's fall snapped a three-day winning streak.

The stock was the top percentage gainer on the Nifty Pharma index, which traded 0.3% higher compared to a 0.8% loss in the ...

Glenmark Pharmaceuticals' shares surged 10% to an all-time high of ₹2,094 following the announcement of an exclusive ...

Comments by Abbvie CEO, Rob Michael, that the tax reforms in 2017 by President Trump enabled it to buy Allergan and the ...

The global Botulinum Toxins Market, valued at US$8.1 billion in 2024 stood at US$8.9 billion in 2025 and is projected to advance at a resilient ...

Glenmark Pharma's exclusive licensing deal with AbbVie for ISB-2001 could be transformative, offering significant upside ...

Browse in-depth TOC on Botulinum Toxins Market 400 - Tables 50 - Figures 320 - Pages By product,Botox has a wide range of ...

AbbVie Inc. defeated class action claims it misled investors about the role kickbacks played in the success of its arthritis ...

The shares of the prominent pharmaceutical company broke the upper band, gained up to 15 percent in today's trading session ...

Tremfya snagged Dupixent’s place as the pharma brand with the most TV impressions in June, according to data released by iSpot.tv on Friday morning. The Johnson & Johnson brand garnered a 4.3% share ...